ClinicalTrials.gov
public full text
Public Domain
Fludarabine and Cytarabine Versus High-dose Cytarabine for CBF-AML
The purpose of the study is to determine whether Fludarabine in combination with cytarabine is more effective than high-dose cytarabine in post-remission therapy for patients with core-binding factor acute myeloid leukemia
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Timed-Sequential Induction in CBF-AML#1095956
- Phase 2 Fludarabine, Cytoxan and FCCAM <Alemtuzumab> in Untreated B-Cell Chronic Lymphocytic Leukemia#906662
- Efficacy of FLAG Regimen for the Treatment of Patients With AML#1127539
- A Study to Evaluate the Pharmacokinetic Profile of CBL-514 Injection in Healthy Volunteers#993005
- High-dose Cytarabine and Survival in AML#830461
Record · ID 981309
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive